FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel
October 02, 2015 at 04:19 AM EDT
Sandoz, a Novartis (NYSE: NVS) company and the global leader in biosimilars, announced today that the US Food and Drug Administration ...
